[ Price : $8.95]
Federal Register Notice: FDAs Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Co...[ Price : $8.95]
Federal Register Notice: FDA adds an omitted footnote to a Federal Register notice that withdrew approval of 27 NDAs and 58 ANDAs.[ Price : $8.95]
A Journal of Clinical Oncology commentary criticizes an alleged FDA regulatory bias against requiring cancer-treating drugs to be...[ Price : $8.95]
A new FDA study finds no detectable levels of the suspected mutagen bisphenol A in the fetuses of pregnant rats orally administere...[ Price : $8.95]
Attorney John Fleder highlights continuing confusion that exists over FDAs position on off-label drug promotion.[ Price : $8.95]
FDA says that in the second quarter of 2011 it identified potential safety signals in 10 drugs.[ Price : $8.95]
Attorney Arnie Friede says FDA and the courts have made differing interpretations of federal preemption law depending on the drug,...[ Price : $8.95]
FDA clears an Iris International 510(k) for its NADiA ProsVue prognostic cancer test for identifying patients at reduced risk for ...